INTERNATIONAL PATENT: ALZMED INC., 알츠메드 주식회사 FILES APPLICATION FOR "GENE THERAPY METHOD FOR TREATING MUSCULAR DYSTROPHY AS GENETIC DEFECT DISEASE AND GENE THERAPY PRODUCT USING SAME"

GENEVA, March 3 -- ALZMED INC. (309, 105-1, Seoul National University Institute of Molecular Biology and Genetics, 1, Gwanak-roGwanak-guSeoul 08826), 알츠메드 주식회사 (서울특별시관악구관악로 1, 105-1동 서울대학교 유전공학연구소, 309호) filed a patent application (PCT/KR2025/006334) for "GENE THERAPY METHOD FOR TREATING MUSCULAR DYSTROPHY AS GENETIC DEFECT DISEASE, AND GENE THERAPY PRODUCT USING SAME" on May 12, 2025. With publication no. WO/2026/043007, the details related to the patent application was published on Feb 26, 2026.

Notably, the pa...